Search results for: 'past growth changers'

This growth opportunity-technology (GO-TE) study identifies and analyzes some of the key developments in diagnostic medical devices across major therapeutic areas such as cardiology, neurology, and oncology. The research highlights the breakthrough diagnostic medical device technologies that are likely to be approved in the next 2-3 years. These pr...

Therapeutic medical devices play a significant role in the long-term treatment of chronic conditions such as cancer and neurological diseases. Non-invasive therapeutic medical devices capable of offering home-based treatment provide high patient comfort and adherence to the prescribed therapy. With the changing preference of the patients, the medic...

The pharmaceutical and biotechnology industries are entering a transformative era in 2025, shaped by a convergence of scientific innovation, regulatory evolution, and market pressures. One of the key imperatives is the continued advancement of therapeutics and drug approvals, as breakthrough treatments, particularly in personalized medicine, promis...

The global pharmaceutical market is projected to reach approximately $1.72 trillion in 2026, with large molecules driving most incremental growth while small molecules remain the sector’s cash flow base. The current growth cycle concentrates on cardiometabolic and oncology, led by GLP-1 platforms and antibody–drug conjugates (ADCs). Competitive adv...

Emerging endoscopy technologies leverage advanced surgical visualization and instrumentation techniques during the pre-operative and intraoperative phases of surgical procedures. The use of these techniques helps surgeons to clearly visualize, accurately identify, and localize anomalies, and subsequently navigate and perform complex surgeries with ...

Advanced visualization and robotic tools during the pre-operative and intraoperative phases of a procedure allow surgeons to identify and localize targets so that they can navigate and perform complex surgeries with precision, minimizing invasiveness, improving recovery times, and lowering the risk of post-procedure complications. This Frost & ...

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and translation of blood-based neurology biomarkers, sustai...

26 Aug 2024  |  Global  |  Market Research

Growth Opportunities in the Tissue Diagnostics Industry, Global, 2024 2029

Companion Diagnostics-specific Advanced Staining and Multiomics Capabilities are Driving Market Growth

Infographics

×

The global tissue diagnostics market will experience significant growth driven by the need for advanced staining in precise biomarker identification in personalized medicine, tissue biopsy test volumes, and pre-analytical and advanced staining platform development. According to the WHO, there will be a 60% rise in cancer cases worldwide by 2040,...

Frost & Sullivan’s Medtech and Imaging programs explore, articulate, and address the medical industry’s most pressing questions related to growth. The programs focus on core segments such as care delivery, care management, imaging informatics, intelligent imaging, and business models. They independently review and identify companies that are produc...